Jury Finds Monsanto’s Roundup Responsible for Man’s Cancer

A San Francisco court levels $289 Million in damages against the pesticide maker.

Written bySukanya Charuchandra
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: ©ISTOCK, AMYKERK

ASuperior Court jury in California on August 10 granted Dewayne Johnson $289 million in damages from Monsanto for its Roundup weed killer having caused his cancer. This is the first of more than 5,000 lawsuits Monsanto faces for its glyphosate-based weed killers. Johnson's case, filed in 2016, was fast-tracked because of the speed at which his non-Hodgkin lymphoma was progressing, according to Reuters.

The San Francisco jury took three days to deliver its verdict. Jury members agreed the company should have labeled Roundup as hazardous. One of Johnson’s lawyers, Brent Wisner, says in a statement that Monsanto knew “glyphosate and specifically Roundup could cause cancer,” according to company records.

After the trial, Scott Partridge, Monsanto’s vice president for global strategy, said the documents had been “taken completely out of context,” according to The Guardian. He added that the trial doesn't alter “the four-plus decades of safe use ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies